Contact
Mr Mohamed Ismail

Mr Mohamed Ismail

Consultant Urologist
MBChB, MRCS, PhD, FRCS(Urol)

Practising at

Spire Portsmouth Hospital

Back to top

Treatment information

Some of the principal treatments carried out by Mr Mohamed Ismail at Spire include:

Urology

Other treatments

  • Endoscopic Kidney Stone Treatment
  • Holmium laser enucleation of the prostate (HoLEP)
  • Percutaneous Nephrolithotomy Prostate Resection (TURP)

Back to top

Professional profile

I joined Portsmouth Hospitals NHS Trust as a consultant urological surgeon in 2016. I specialise in treating kidney stone and laparoscopic (key hole) surgery for kidney diseases. I graduated at Baghdad University in 1999 and completed my PhD degree in urology at the University of Surrey in 2009.

My research concentrated on the molecular and immunological treatment for prostate cancer. I undertook my postgraduate specialist urological training in the Southwest of England. I have also completed a further 20 months of stone and laparoscopic fellowship in the Bristol Urological institute in 2015.

I gained a valuable experience in the management of complex kidney stone diseases and minimally invasive access treatment for kidney cancer and benign kidney diseases. I perform a high volume of flexible ureteroscopy to treat kidney stones.

I also have training and experience in laparoscopic surgery for non functioning kidneys and pelviureteric junction obstruction (PUJO). I am passionate about delivering the highest quality of clinical care and increasing the public awareness and knowledge of stone disease.

I specialise in treating kidney stone disease with ureteroscopy, PCNL and ESWL (shock wave lithotripsy).


Clinical Interests

Bladder/ kidney stone disease
Urodynamics
Urology

Special Clinical Interests: Laparoscopic nephrectomy and pyeloplasty, general urology including benign prostate surgery.

Private contact details

Private secretary Alison Moore
Private secretary telephone 02392 365 010
Private secretary email amppsec@gmail.com

Media Coverage

Dear doctor, is there anything I can do to prevent developing kidney stones?

Back to top

Qualification and professional memberships

MBChB / Baghdad, Iraq / 1990
Medicine and Surgery

MRCS (Eng) / Royal college of Surgeons England, UK / 2005
Basic surgical qualification

PhD / University of Surrey, UK / 2009
Doctor of Philosophy

FRCS (Urol) / Royal College of Surgeons England, UK / 2014
Advanced fellowship in upper tract laparoscopy and kidney stone treatment

Post CCT Fellowship / Bristol Urological Institute / 2015
Advanced fellowship in upper tract laparoscopy and management of kidney stone


Professional memberships

European Association of Urology (EAU)
Royal College of Surgeons of England

Back to top

Current NHS posts

Queen Alexandra Hospital Portsmouth Hospitals NHS trust

Back to top

Research and Publication


Articles

An interventional urology list– a novel concept for UK urological services.

Prognostic value of initial prostate specific antigen levels after salvage cryoablation for prostate cancer.

Clinical Review - Prostatitis

Engraile-2 (EN2): a highly specific urinary biomarker for the early diagnosis of prostate cancer.

Ciprofloxacin resistant infection following transrectal ultrasound guided prostate biopsy: should we reassess our practice?

Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.

Entonox® inhalation to reduce pain in common diagnostic and therapeutic outpatient urological procedures: a review of the evidence.

Complication of fungal cystitis

Dutasteride/tamsulosin fixed dose combination for the treatment of benign prostatic enlargement.

Penile intraepithelial neoplasia: management and outcome

Update on the management of overactive bladder syndrome

Contemporary treatment options for chronic prostatitis/chronic pelvic pain syndrome.

Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer.

Back to top